ARTICLE | Clinical News
Foznol lanthanum carbonate formulation regulatory update
March 19, 2001 8:00 AM UTC
SHP submitted an application for European marketing approval of Foznol, a dietary phosphate binder taken with food to reduce serum phosphate levels in patients with chronic renal failure. Last year, S...